There still exists downside risk on CCEP despite the 64% fall in share price since listing; and key negative catalysts are overly aggressive capacity targets and potential earnings disappointments.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.